2025 POP Annual Report
Read about all the exciting activities in the Department of Pharmaceutical Outcomes and Policy over the past year.
All Posts by
Matthew Splett
The Conversation: Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse
Almut Winterstein, distinguished professor of pharmaceutical outcomes and policy, co-authored the story published in The Conversation.
Study: Many pregnant women uncertain of marijuana risks even as use increases
Amie Goodin, Ph.D., an assistant professor in Department of Pharmaceutical Outcomes and Policy is the study's lead author.
Faculty Opening: Assistant, Associate or Full Professor (Tenure Track)
The Department of Pharmaceutical Outcomes and Policy invites applicants for a full-time faculty position.
Dr. Haesuk Park promoted to professor
Dr. Park was among six faculty members promoted in the UF College of Pharmacy this summer.
Cannabis Clinical Outcomes Research Conference celebrates fifth year of advancing medical marijuana research
More than 120 scientists and medical professionals dedicated to evidence-based cannabis research attended the two-day event in Orlando.
Dr. Chanakan Jenjai awarded P.E.O. International Peace Scholarship
Dr. Jenjai will receive $5,000 in scholarship support from the P.E.O.
Dr. Steven Smith named to National Academies of Sciences, Engineering, and Medicine committee
Dr. Steven Smith will serve on the National Academies of Sciences, Engineering, and Medicine consensus study Committee on Clinical Preventive Services for Addressing Cardiovascular Disease Risk to Reduce Pregnancy-related Deaths Among Women.
Read the 2024 POP Annual Report
Recap all the grants, publications and awards in the past academic year.
New study in JAMA Neurology examines cardiovascular risk in using migraine-prevention medications
Seonkyeong Yang, Ph.D., M.S., a 2024 graduate of the Department of Pharmaceutical Outcomes and Policy, served as the publication's lead author.
